Long Term Remission Rates from a Biologic Clinic: 12 Year Real World Data

被引：0
|
作者：
Murray, Kieran [1 ]
Turk, Matthew [1 ]
Alammari, Yousef [1 ]
Young, Francis [1 ]
Gallagher, Phil [2 ]
Saber, Tajvur [3 ]
Maguire, Sinead [4 ]
O'Shea, Finbar [4 ]
Fearon, Ursula [5 ]
Veale, Douglas [6 ]
机构：
[1] St Vincents Univ Hosp, Dublin 4, Ireland
[2] UCD, St Vincents Univ Hosp, Dublin, Ireland
[3] Peshawar Rheumatol Clin, Dabgari Garden, Northern Areas, Pakistan
[4] St James Hosp, Dublin, Ireland
[5] Trinity Coll Dublin, Mol Rheumatol, Dublin, Ireland
[6] UCD, St Vincents Univ Hosp, EULAR Ctr Arthrit & Rheumat Dis, Dublin, Ireland
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0810
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Long-term remission and biologic persistence rates: 12-year real-world data
    Murray, Kieran
    Turk, Matthew
    Alammari, Yousef
    Young, Francis
    Gallagher, Phil
    Saber, Tajvur
    Fearon, Ursula
    Veale, Douglas J.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [2] Long-term remission and biologic persistence rates: 12-year real-world data
    Kieran Murray
    Matthew Turk
    Yousef Alammari
    Francis Young
    Phil Gallagher
    Tajvur Saber
    Ursula Fearon
    Douglas J. Veale
    [J]. Arthritis Research & Therapy, 23
  • [3] Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis
    Boschitsch, Ewald
    Naegele, Oliver
    Klinger, Anita
    Brix-Samoylenko, Harald
    [J]. OSTEOPOROSIS INTERNATIONAL, 2022, 33 (01) : 263 - 272
  • [4] Long-term persistence with denosumab: real-world data from the Austrian Osteoporosis Clinic (AOC). A retrospective data analysis
    Ewald Boschitsch
    Oliver Naegele
    Anita Klinger
    Harald Brix-Samoylenko
    [J]. Osteoporosis International, 2022, 33 : 263 - 272
  • [5] First year remission rates among patients with newly diagnosed Crohn's disease: data from a real-world prospective inception cohort
    Yanai, H.
    Fischler, T. Sharar
    Goren, I.
    Ollech, J.
    Snir, Y.
    Broitman, Y.
    Barkan, R.
    Peffer-Gik, T.
    Raykhel, B.
    Kutukov, L.
    Friedeberg, A.
    Pauker, M.
    Eran-Banai, H.
    Avni-Biron, I.
    Dotan, I.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I210 - I211
  • [6] FIRST YEAR REMISSION RATES AMONG PATIENTS WITH NEWLY DIAGNOSED CROHN'S DISEASE: DATA FROM A REAL-WORLD PROSPECTIVE INCEPTION COHORT
    Yanai, Henit A.
    Fischler, Tali Sharar
    Goren, Idan
    Ollech, Jacob
    Snir, Yifat
    Broitman, Yelena
    Barkan, Revital
    Pfeffer-Gik, Tamar
    Raykhel, Barbara
    Kutukov, Yelena
    Friedenberg, Adi
    Pauker, Maor H.
    Banai, Hagar
    Avni-Biron, Irit
    Dotan, Iris
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S434 - S434
  • [7] HIGH REMISSION RATES IN RA - REAL LIFE DATA FROM BARITICINIB
    Bayat, S.
    Tascilar, K.
    Kaufmann, V.
    Kleyer, A.
    Simon, D.
    Knitza, J.
    Hartmann, F.
    Adam, S.
    Hueber, A.
    Schett, G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1459 - 1460
  • [8] High Remission Rates in RA - Real Life Data from Bariticinib
    Bayat, Sara
    Tascilar, Koray
    Kleyer, Arnd
    Simon, David
    Hueber, Axel
    Schett, Georg
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [9] Real-world experience with inclisiran: 12 month data from the Hammersmith Hospital Lipid Clinic
    Jackson, E. K.
    Padam, P.
    Barton, L.
    Wilson, S.
    David, A.
    Walji, S.
    de Lorenzo, F.
    Ray, K. K.
    Jones, B.
    Cegla, J.
    [J]. ATHEROSCLEROSIS PLUS, 2023, 54 : S5 - S6
  • [10] LONG-TERM SAFETY OF TOFACITINIB: REAL WORLD DATA FROM A TERTIARY CENTER
    Cohen, Nathaniel A.
    Steinberg, Joshua M.
    Silfen, Alexa
    Traboulsi, Cindy
    Singer, Jorie
    Patel, Shivani A.
    Cohen, Russell D.
    Dalal, Sushila
    Micic, Dejan
    Pekow, Joel R.
    Sakuraba, Atsushi
    Rubin, David T.
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S342 - S343
12345